Korean Medical Startup Cellbion Raises KRW 8 billion for Innovative Cancer Radiotherapy Drug
Korean medical radioisotope-based cancer therapeutics developer, Cellbion, has raised KRW 8 billion in a pre-IPO round, featuring investors like Hana Ventures,...